Highlights:

  • Lab diagnostic test development
  • Access to CLIA/CAP lab for clinical research trials
  • Solution for sample collection through to commercial development

Epigenetic Biomarker Discovery Program

Zymo Research offers a new Epigenetic Biomarker Discovery Program for the development of epigenetic lab diagnostic tests. Whether you are interested in developing epigenetic tests for cancer, developmental disorders, autoimmune diseases, obesity or other anomalies, Zymo Research provides a solution for sample collection through to commercial development. The experts at Zymo Research can help you at any step in the development pipeline by offering a portfolio of products and services for sample collection and purification, biomarker discovery, biomarker validation, platform selection, and commercial development.

Your Cart